European Association for the Study of Diabetes (EASD) Annual Meeting 2026 Milan, Italy 28 September 2026 - 02 October 2026 Survodutide reduces weight in adults with obesity, T2D 15 Oct 2026 byStephen PadillaStephen Padilla Treatment with the investigational glucagon/GLP-1 receptor dual agonist (RA) survodutide results in significant weight reductions in adults with obesity and type 2 diabetes (T2D), a study has shown.15 Oct 2026 1 1
